Ashton Thomas Securities’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.51M Sell
10,003
-1,646
-14% -$384K 0.37% 53
2026
Q1
$2.85M Buy
11,649
+3,532
+44% +$823K 0.36% 67
2025
Q4
$1.68M Buy
8,117
+738
+10% +$146K 0.32% 72
2025
Q3
$1.37M Buy
7,379
+4,711
+177% +$807K 0.19% 117
2025
Q2
$408K Sell
2,668
-134
-5% -$20.6K 0.1% 188
2025
Q1
$464K Buy
2,802
+537
+24% +$84K 0.13% 159
2024
Q4
$330K Sell
2,265
-2,132
-48% -$330K 0.09% 180
2024
Q3
$713K Buy
+4,397
New +$701K 0.14% 149

Other funds holding JNJ

Ashton Thomas Securities's JNJ Position: Q2 2026 in Review

Ashton Thomas Securities reduced its Johnson & Johnson (JNJ) stake by 14% in Q2 2026, selling an estimated $384K and leaving 10,003 shares worth $2.51M. The position accounts for 0.37% of the portfolio, ranked #53.

Ashton Thomas Securities first reported a position in JNJ in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.85M in Q1 2026. 4,678 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Ashton Thomas Securities held 10,003 shares of Johnson & Johnson worth $2.51M as of Q2 2026.
  • Ashton Thomas Securities sold 1,646 Johnson & Johnson shares in Q2 2026, an estimated $384K.
  • Johnson & Johnson made up 0.37% of Ashton Thomas Securities's portfolio in Q2 2026, its #53 holding.
  • Ashton Thomas Securities first reported a position in Johnson & Johnson in Q3 2024 and has held it in 8 quarters since.
  • Ashton Thomas Securities's Johnson & Johnson position peaked at $2.85M in Q1 2026.
  • 4,678 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Ashton Thomas Securities's 13F filing for Q2 2026, filed 27 Jul 2026.